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between HBV replication and the expressions of transforming
growth factor (TGF)-β1 and insulin-like growth factor-II (IGF-II)
in tissues of hepatocellular carcinoma (HCC).
Methods: Liver HBV-DNA was detected by in situ molecular hy-
bridization technique, and the expressions of TGF-β1 and IGF-II
were detected by the immunohistochemistry, and TGF-β1 mRNA
and IGF-II mRNA were ampliﬁed by nested-PCR assay in HCCs
and their self-control non- cancerous tissues. The relationship
was investigated between TGF-β1 or IGF-II expression and HBV
replication or their clinical pathological characteristics.
Results: The stronger expressions (83.3%) of TGF-β1 and IGF-II
were found, and the incidences of TGF-β1 mRNA and IGF-II mRNA
were 100% in HCC tissues. A signiﬁcant difference was presented
between in HCC tissue and in non-cancerous liver tissues
(P<0.01). The positive rate of TGF-β1 in HCC was correlated
to tumor differentiation, but neither to tumor size nor numbers
(P>0.05). The levels of TGF-β1 and IGF-II expression were
signiﬁcantly associated with HBV replication with higher HBV-
DNA-positive HCC (94.7%) than that in HBV-DNA-negative group.
Conclusion: TGF-β1 and IGF-II in HCC are overexpressed and as-
sociated withhepatic HBV replication and differentiation degree
of HCC.
PP-104 Chronic hepatitis B: molecular, epidemiological
and clinical features in northwest and central
Russia
Ekaterina Elpaeva, Elena Poretskova, Andrey Komissarov,
Maria Pisareva, Mikhail Grudinin, Elena Esaulenko*, Oleg Kiselov.
Research Institute of Inﬂuenza RAMS
Objectives: To reveal the HBV genotype distribution and clinical
differences between different genotypes in patients with chronic
hepatitis in 2 regions of Russia, to determine the structure of
HBV DNA fragments responsible for resistance to treatment.
Methods: HBV genotyping was carried out by original PCR
method. Sequencing with original primers was performed. Real
time PCR was used to determine viral load in patients’ blood
and liver biopsies. Disease severity was evaluated by clinical-
laboratory markers and morphology study.
Results: 325 patients with chronic hepatitis B (Mean age - 34
years. Female to male ratio - 2:1) were observed. HBV genotype
was determined in 294 patients from Saint Petersburg region
and 31 patients from Central part of Russia (Perm city). HBV D
genotype was revealed in 96% of cases in North West and in 67% of
cases in Central Russia. In the rest of cases A genotype was deter-
mined. More severe disease with necro-inﬂammatory inﬁltration
and ﬁbrosis progression was diagnosed in patients with HBV A
genotype. Some patients from this group had hepatocirrhosis.
95% of patients with HBV D genotype were HBeAg-negative. HBV
polymerase gene fragment sequencing from 28 patients revealed
high variability of viral genome and YMDD-motif characteristic
for wild type (lamivudin susceptible).
Conclusion: HBV genotypes A and D are circulating in North West
and Central Russia. The percentage of prevalent D genotype is
much higher in the North West region. Prevalence of mutant
D genotype HBV enforces to include nucleoside analogues in
therapeutic course of HBV chronic patients.
PP-105 Development of an ELISA kit for detection of
HBsAg in human serum
Marjan Rahsaz*,1, Daryoush Tayyebi 2. 1Shiraz Transplantation
Research Center; 2Islamic Azad University, Kazeroun Branch
Background: Hepatitis B virus, the cause of serum hepatitis, is
classiﬁed as a hepadnavirus. HBV is responsible for acute and
chronic infections and may ultimately lead to cirrhosis or pri-
mary hepatocellular carcinoma. HBV have various antigens, the
important of which is surface antigen or HBsAg.
The particles containing HBsAg are antigenically complex. In con-
trast to the other HBV antigens, HBsAg is an important diagnostic
marker of an active hepatitis B infection. Emphasis of this study
is to develop a direct sandwich ELISA method for detection of
HBsAg in the human serum.
Methods: In summary, the surface of well of microplate was
coated by mouse monoclonal anti-HBs with the concentration of
1 J.1g1mTl.he serum or plasma sample added to the wells of
microplate after they had been saturated by BSA. Then, diluted
anti-HBs-HRP (1/8000) was added to each well which was able
to connect to the trapped HBsAg. The ﬁnal colorometric detec-
tion of HBsAg is performed by adding a solution of substrate of
peroxidase enzyme to each well. The color intensity is directly
proportional to the concentration of HBsAg in serum.
Results: The sensitivity and speciﬁcity of the developed method
was studied on 1350 serum samples. The results indicated a 96%
sensitivity and 98.8% speciﬁcity. The precision of this method
was determined by the %CV for inter-assay and intra-assay.
Conclusions:We can develop a direct sandwich ELISA method for
detection of HBsAg in the human serum with 96% sensitivity and
98.8% speciﬁcity.
PP-106 Analysis of lymphocyte subsets of peripheral
blood in patients with acute self-limited
hepatitis B
Bo Liu, Yanping Han, Yuan Liu, Yang Cao, Lianhua Kong, Jun Li *.
The First Afﬁliated Hospital with Nanjing Medical University
Objectives: To investigate changes and signiﬁcance of lympho-
cyte subsets (T lymphocytes, B lymphocytes, NK cells and T cell
subsets) of peripheral blood in patients with acute self-limited
hepatitis B (AHB) with changes.
Methods: By ﬂow cytometry (FCM), immune cells of peripheral
blood were comparied among 23 cases of self-limited acute hep-
atitis B patients, 36 patients with chronic hepatitis B (CHB) and
32 healthy controls; CD4+/CD8+ and ALT were monitored dynam-
iclly, meanwile the relation between T lymphocyte subsets and
ALT were explored.
Results: The level of CD3+ T cells (75.02±8.71%), CD3+CD4+T
cells (43.32±6.73%) and the ratio of CD4+/CD8+ (2.35±0.51%)
of AHB have signiﬁcantly increased compared to CHB group
(62.48±11.33%, 33.07±9.67%, 1.14±0.31% respectively) and
healthy group (64.00±11.54%, 34.41±7.53%, 1.41±0.61% respec-
tively); Dynamic monitoring of CD4+/CD8+, ALT, CD4+/CD8+ had
an increased trend, accompanied by lower ALT. And CD4+/CD8+
had no signiﬁcant relation to HBV-DNA for HBV-DNA positive AHB.
Conclusion: Immune status of AHB, compared to CHB and healthy
controls, were signiﬁcantly different and changes of T lympho-
cyte subsets were related to progress of disease.
PP-107 Up-regulation of expression of B7-H1 and its
receptor PD-1 on PBMC by HBeAg
Jun Li *, Yaping Han, Bo Liu, Jie Cai, Yuan Liu, Lianhua Kong,
Zuhu Huang. The First Afﬁliated Hospital with Nanjing Medical
University
Objectives: To study HBeAg does impact on molecule expression
of B7-H1 and PD-1 as well as TLR2 on PBMC.
Methods: PBMC from different infectious status of CHB patients
were stimulated by recombinant HBeAg, and expression of B7-
H1, PD-1 and TLR2 on PBMC before and after stimulation as well
as changes in lymphocyte subsets were quantitativly analysized
on FACS, changes in expression of PBMC surface receptor above
were further observed by using blocked method of HBeAb, in or-
der to conﬁrm HBeAg-speciﬁc function, while analysizing growth
and decline of cytokines in culture supernatant before and after
stimulation.
Results: When PBMC from HBeAg-negative CHB patients and
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HBeAg were co-incubated for 6h, compared to that of before
stimulation, expression of B7-H1 on CD14+ cells increased, ex-
pression of TLR2 decreased, expression of B7-H1 and PD-1 on
CD4+ and CD8+ T cells increased signiﬁcantly, expression of cos-
timulatory molecules CD28 on CD4+ cells decreased;Inﬂammatory
factor TNF-α and anti-viral cytokine IFN-γ of HBeAg-stimulated
PBMC from HBeAg-negative CHB patients, increased and reduced
respectively.
Conclusion: By up-regulating expression of B7-H1 and PD-
1,HBeAg may inhibit expression of TLR2 on CD14+ cells, reduce
expression of costimulatory molecules CD28 on T lymphocyte,
inhibit polarization of Th cells, and reduce active secretion of
anti-viral factor of patients, which leaded to function of speciﬁc
cell-mediated immunity became low, thereby clearance of virus
by T lymphocyte were suppressed, which eventually resulted in
persistence of HBV infection.
PP-108 Detecting hepatitis B virus large surface protein in
patients with chronic hepatitis B: a clinical study
Zheng-lin Wu*, Peng Zhuang, Xue-dong Lu, Jian Liu,
Xiao-qiang Zhong. The Fourth People’s Hospital of Shenzhen
Objective: To investigate the clinical signiﬁcance of hepatitis B
virus large protein (HBLP) detection in prediction of HBV DNA
replication and the effect of anti-viral treatment.
Methods: The Serum samples were collected from 90 patients
with HBV infection before and after anti-viral treatment. HBV
DNA level was quantitatively detected using real-time poly-
merase chain reaction. HBLP was measured by enzymelinked
immunosorbent assay (ELISA). The collected data were analyzed
by bivariate correlations method.
Results: There was no signiﬁcant difference between the de-
tectable rates of HBV DNA and HBV-LP in 90 blood samples before
treatment (p>0.05); The levels of serum HBV-LP was positively
correlated with HBV DNA copies during anti-viral treatment
(r=0.857, P=0.000). The OD value of HBV-LP and the copies of
HBV-DNA decreased in the same trend along with treatment.
Conclusion: HBLP expression can reﬂect the state of HBV DNA
replication. The decrease of HBLP and HBV-DNA during the anti-
viral treatment could estimate the HBV replication state and
predict the effect of anti-viral treatment.
PP-109 A study for HBsAg routine test negative results
Zheng-lin Wu*, Jian Liu, Xiao-qiang Zhong, Guang-cheng Lin,
Xue-dong Lu. The Fourth People’s Hospital of Shenzhen
Objective: To see the false HBsAg negative results for serum
samples in daily work and to improve the clinical laboratory tests
quality.
Methods: Four hundreds HBsAg negative stochastic serum sam-
ples were collected from the copy tubes in daily work for
detecting hepatitis B Virus markers (HBVM) with national ELISA
reagent kits divided into 200 samples with HBsAb negative and
200 positive and put them −20° frostily. HBsAg markers were
counterchecked with other two adding kinds of national reagent
and American MONOLISA HBsAg ULTRA reagents (total 4 kinds)
at the 400 samples and ﬁltrated the positive samples. At the
last ﬁltrated samples, HBV DNA levels were doubly quantitative
analyzed with ﬂuorescence quantitative PCR (FQ-PCR) and taking
the mean results.
Results:We educed the conform HBsAg negative results from the
three kinds of national reagents but ﬁve positive results from
the American reagents in repeating HBsAg detection at the 200
HBsAb negative samples. No positive results were checked out
from the 200 HBsAb positive samples with national or foreign
reagents. The HBV DNA FQ-PCR quantitative results were all
positive but less than 500 copies/ml.
Conclusion: The sensitive level of the HBsAg routine test ELISA
reagents is generally on the low side and easily bring on the false
HBsAg negative results and the false results are more frequently
from the HBsAb negative people. This maybe connected with
occult HBV infection, we should attach importance to the HBVM
counterchecking work at these people.
PP-110 Detecting hepatitis B virus large surface protein
to ﬁltrate the occult HBV infection
Zheng-lin Wu*, Jian Liu, Xiao-qiang Zhong, Guang-cheng Lin,
Xue-dong Lu. The Fourth People’s Hospital of Shenzhen
Objective: Detecting hepatitis B virus large surface protein
(HBLP) with serological method to ﬁltrate the occult HBV infec-
tion and study the clinical detection strategy.
Methods: Two thousands HBsAg negative stochastic serum sam-
ples were collected from the copy tubes in daily work to detect
hepatitis B Virus markers (HBVM) with national ELISA reagent kits
and put them –20° frostily. The 2000 samples were detected with
HBLP and ﬁltrated the positive samples. HBsAg markers were
doubly counterchecked with other two adding kinds of national
ELISA reagent kits (total 3 kinds) at the ﬁltrated samples. The
last samples were doubly tested again with American MONOLISA
HBsAg ULTRA reagents. HBV DNA levels were quantitative an-
alyzed with ﬂuorescence quantitative PCR (FQ-PCR) and taking
the mean results.
Results: Fifteen HBLP positive samples were detected out from
the 2000 serum samples. The conform negative results were
educed from the three kinds of national reagents but conform
positive results from the American reagents in repeating HBsAg
detection at the 15 samples. The HBV DNA FQ-PCR quantitative
results were all positive but less than 500 copies/ml.
Conclusion: The false HBsAg negative results for serum samples
are more generally from national reagents than from impor-
tations and HBLP results may be positive in these samples.
Detecting HBLP marker is propitious to ﬁltrate the occult HBV
infection. This study provided a kind of serological reference
for actively searching for the detecting strategy in occult HBV
infection ﬁeld.
PP-111 Evolution of hepatitis B virus in a chronic
HBV-infected patient over 2 years
Tao Shen*, Yun Lian Zou, Xin Min Yan, Hong Dong. The Institute
of Basic Medicine
Background: Evaluation of a 3-year evolution of hepatitis B virus
in a chronically infected patient was conducted.
Methods: Clinic data and HBV DNA load(s) in serum were de-
tected at three time points (1 day, 6 month and 31 month), HBV
isolates were obtained at each time.The full-length HBV genome
was cloned and 26 clones including three time points were
randomly selected, sequenced and phylogenetically analyzed.
Results: All of the 26 clones belonged to subgenotype C2. 13 nu-
cleotides in this subset of clones were found to be different from
the published sequences of genotype C of HBV. During the 3-year
evolution, nucleotides T361A, C930A, C2351T/A2353T, C2444T
were the mutations been kept in and from minor to major while
C339T and T770C were the new point mutations at the 3rd time
point (31 month). Short fragment deletion (nt2849 to 2867) in the
preS gene became dominant at the 31-month time point and had
a trend to lead to large fragment deletion, which may produce
presumptive P/S fusion proteins or truncated preS proteins. At
the third time point, the patient’s serum ALT, HBeAg and load of
HBV DNA varied greatly.
Conclusion: The evolutionary data of HBV may provide clues for
the interpretation of the course of HBV chronic infection and
progressive pathology of liver diseases.
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